Views & Analysis Digital health and pharma – adapting to the post-coronavirus... The need for digital transformation and a response model for coronavirus were among the topics discussed in a recent digital debate
Views & Analysis Deep Dive: Market Access - Breaking Barriers In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.
Views & Analysis 6 ways to digitise your business at pace As the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact?
Views & Analysis Coronavirus pharma news roundup 15/5/20 This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs as studies – and approvals – continued apace.
Views & Analysis What COVID-19 means for generics companies Generics companies have found themselves at the forefront of fighting COVID-19 – but it has required rapid change at all levels of the business.
Views & Analysis Coronavirus pharma news roundup – 1/5/2020 This week saw several pharma companies reveal how the coronavirus pandemic has affected their sales.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.